Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® (Insulin Aspart Injection)

NCT05224258 is registered in ClinicalTrials.gov with Medtronic MiniMed, Inc. as lead sponsor.

NCT NCT05224258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05224258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® (Insulin Aspart Injection)
Lead sponsor
Medtronic MiniMed, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 17, 2022
Completion date
June 21, 2024
Enrollment
240 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes